Global Plasmid Service 麻豆原创 Research Report 2024

Publication ID:

PB508240273

Publication Date:

August 27, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Plasmid Service is an outsourcing service that provides plasmid design, construction, purification and analysis for scientific research, gene therapy, drug development and biotechnology. Plasmids are circular DNA molecules used for gene cloning, expression and delivery, and are commonly used tools in molecular biology research. Plasmid services usually cover the entire process from vector design, gene insertion, mutation generation, sequence verification to high-purity preparation, and are suitable for a variety of application scenarios such as basic research, gene therapy development, vaccine production and protein expression.
The global Plasmid Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Plasmid Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Plasmid Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Plasmid Service in Gene Therapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Plasmid Service include Genewiz, Addgene, Charles River, GenScript, Creative Biogene, VectorBuilder, Takara Bio, PlasmidFactory, GeneCopoeia, Aldevron, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Plasmid Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid Service.
The Plasmid Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasmid Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasmid Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Genewiz
Addgene
Charles River
GenScript
Creative Biogene
VectorBuilder
Takara Bio
PlasmidFactory
GeneCopoeia
Aldevron
OriGene
Biomatik
Segment by Type
Plasmid Preparation Service
Plasmid Purification Service
Others
Segment by Application
Gene Therapy
Gene Function Research
Vaccine Development
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasmid Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Plasmid Service 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Plasmid Preparation Service
1.2.3 Plasmid Purification Service
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Plasmid Service 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Gene Therapy
1.3.3 Gene Function Research
1.3.4 Vaccine Development
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasmid Service 麻豆原创 Perspective (2019-2030)
2.2 Global Plasmid Service Growth Trends by Region
2.2.1 Global Plasmid Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Plasmid Service Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Plasmid Service Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Plasmid Service 麻豆原创 Dynamics
2.3.1 Plasmid Service Industry Trends
2.3.2 Plasmid Service 麻豆原创 Drivers
2.3.3 Plasmid Service 麻豆原创 Challenges
2.3.4 Plasmid Service 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid Service Players by Revenue
3.1.1 Global Top Plasmid Service Players by Revenue (2019-2024)
3.1.2 Global Plasmid Service Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Plasmid Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Plasmid Service Revenue
3.4 Global Plasmid Service 麻豆原创 Concentration Ratio
3.4.1 Global Plasmid Service 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid Service Revenue in 2023
3.5 Global Key Players of Plasmid Service Head office and Area Served
3.6 Global Key Players of Plasmid Service, Product and Application
3.7 Global Key Players of Plasmid Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid Service Breakdown Data by Type
4.1 Global Plasmid Service Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Plasmid Service Forecasted 麻豆原创 Size by Type (2025-2030)
5 Plasmid Service Breakdown Data by Application
5.1 Global Plasmid Service Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Plasmid Service Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Plasmid Service 麻豆原创 Size (2019-2030)
6.2 North America Plasmid Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Plasmid Service 麻豆原创 Size by Country (2019-2024)
6.4 North America Plasmid Service 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasmid Service 麻豆原创 Size (2019-2030)
7.2 Europe Plasmid Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Plasmid Service 麻豆原创 Size by Country (2019-2024)
7.4 Europe Plasmid Service 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid Service 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Plasmid Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Plasmid Service 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Plasmid Service 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasmid Service 麻豆原创 Size (2019-2030)
9.2 Latin America Plasmid Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Plasmid Service 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Plasmid Service 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid Service 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Plasmid Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Plasmid Service 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Plasmid Service 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genewiz
11.1.1 Genewiz Company Details
11.1.2 Genewiz Business Overview
11.1.3 Genewiz Plasmid Service Introduction
11.1.4 Genewiz Revenue in Plasmid Service Business (2019-2024)
11.1.5 Genewiz Recent Development
11.2 Addgene
11.2.1 Addgene Company Details
11.2.2 Addgene Business Overview
11.2.3 Addgene Plasmid Service Introduction
11.2.4 Addgene Revenue in Plasmid Service Business (2019-2024)
11.2.5 Addgene Recent Development
11.3 Charles River
11.3.1 Charles River Company Details
11.3.2 Charles River Business Overview
11.3.3 Charles River Plasmid Service Introduction
11.3.4 Charles River Revenue in Plasmid Service Business (2019-2024)
11.3.5 Charles River Recent Development
11.4 GenScript
11.4.1 GenScript Company Details
11.4.2 GenScript Business Overview
11.4.3 GenScript Plasmid Service Introduction
11.4.4 GenScript Revenue in Plasmid Service Business (2019-2024)
11.4.5 GenScript Recent Development
11.5 Creative Biogene
11.5.1 Creative Biogene Company Details
11.5.2 Creative Biogene Business Overview
11.5.3 Creative Biogene Plasmid Service Introduction
11.5.4 Creative Biogene Revenue in Plasmid Service Business (2019-2024)
11.5.5 Creative Biogene Recent Development
11.6 VectorBuilder
11.6.1 VectorBuilder Company Details
11.6.2 VectorBuilder Business Overview
11.6.3 VectorBuilder Plasmid Service Introduction
11.6.4 VectorBuilder Revenue in Plasmid Service Business (2019-2024)
11.6.5 VectorBuilder Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Plasmid Service Introduction
11.7.4 Takara Bio Revenue in Plasmid Service Business (2019-2024)
11.7.5 Takara Bio Recent Development
11.8 PlasmidFactory
11.8.1 PlasmidFactory Company Details
11.8.2 PlasmidFactory Business Overview
11.8.3 PlasmidFactory Plasmid Service Introduction
11.8.4 PlasmidFactory Revenue in Plasmid Service Business (2019-2024)
11.8.5 PlasmidFactory Recent Development
11.9 GeneCopoeia
11.9.1 GeneCopoeia Company Details
11.9.2 GeneCopoeia Business Overview
11.9.3 GeneCopoeia Plasmid Service Introduction
11.9.4 GeneCopoeia Revenue in Plasmid Service Business (2019-2024)
11.9.5 GeneCopoeia Recent Development
11.10 Aldevron
11.10.1 Aldevron Company Details
11.10.2 Aldevron Business Overview
11.10.3 Aldevron Plasmid Service Introduction
11.10.4 Aldevron Revenue in Plasmid Service Business (2019-2024)
11.10.5 Aldevron Recent Development
11.11 OriGene
11.11.1 OriGene Company Details
11.11.2 OriGene Business Overview
11.11.3 OriGene Plasmid Service Introduction
11.11.4 OriGene Revenue in Plasmid Service Business (2019-2024)
11.11.5 OriGene Recent Development
11.12 Biomatik
11.12.1 Biomatik Company Details
11.12.2 Biomatik Business Overview
11.12.3 Biomatik Plasmid Service Introduction
11.12.4 Biomatik Revenue in Plasmid Service Business (2019-2024)
11.12.5 Biomatik Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Genewiz
Addgene
Charles River
GenScript
Creative Biogene
VectorBuilder
Takara Bio
PlasmidFactory
GeneCopoeia
Aldevron
OriGene
Biomatik

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.